Küpeli E, Karnak D, Kayacan O, Beder S
Ankara University School of Medicine, Department of Chest Diseases, Ankara, Turkey.
Postgrad Med J. 2004 Jun;80(944):339-45. doi: 10.1136/pgmj.2003.012435.
Hypersensitivity pneumonitis, also called extrinsic allergic alveolitis, a type of diffuse parenchymal lung disease (DPLD), is an immunologically mediated pulmonary disease induced by inhalation of various antigens. As data on the frequency of hypersensitivity pneumonitis are lacking in Turkey, a retrospective analyses was performed in 43 patients with DPLD, followed up over seven years. The objective was to discover cases fulfilling the diagnostic criteria for hypersensitivity pneumonitis, to determine the frequency and/or the new characteristics of the disease, and to pick up clues for differentiating it from other DPLDs. The four subjects with hypersensitivity pneumonitis (9%) who lived in an urban area were studied in detail. The most common symptoms were dry cough and dyspnoea. According to the symptom duration, clinical features, radiological and pathological findings, three were diagnosed with chronic and one with subacute hypersensitivity pneumonitis. Patients with hypersensitivity pneumonitis and those with DPLD were compared by means of age, sex, smoking status, symptom duration, haematology, erythrocyte sedimentation rate, peripheral cell count, spirometric parameters, blood gases, and diffusion capacity. No statistically significant difference was detected in these parameters except for forced expiratory volume in one second (FEV(1)) and forced vital capacity (FVC). In conclusion, patients with a history of antigen exposure, with mild symptoms such as dry cough and dyspnoea, and who have diffuse interstitial lung involvement on radiology should be carefully evaluated for hypersensitivity pneumonitis. Moreover, among other DPLDs, stable FEV(1) or FVC values may be the clues for establishing the diagnosis of hypersensitivity pneumonitis. However, further studies are needed in larger series of patients.
过敏性肺炎,也称为外源性过敏性肺泡炎,是一种弥漫性肺实质疾病(DPLD),是由吸入各种抗原引起的免疫介导性肺部疾病。由于土耳其缺乏过敏性肺炎发病率的数据,对43例DPLD患者进行了为期七年的回顾性分析。目的是发现符合过敏性肺炎诊断标准的病例,确定该疾病的发病率和/或新特征,并找出将其与其他DPLD区分开来的线索。对居住在城市地区的4名过敏性肺炎患者(9%)进行了详细研究。最常见的症状是干咳和呼吸困难。根据症状持续时间、临床特征、放射学和病理学检查结果,3例被诊断为慢性过敏性肺炎,1例为亚急性过敏性肺炎。通过年龄、性别、吸烟状况、症状持续时间、血液学、红细胞沉降率、外周血细胞计数、肺量计参数、血气和弥散能力对过敏性肺炎患者和DPLD患者进行了比较。除一秒用力呼气量(FEV(1))和用力肺活量(FVC)外,这些参数均未检测到统计学上的显著差异。总之,有抗原接触史、有干咳和呼吸困难等轻微症状且放射学显示有弥漫性间质性肺受累的患者应仔细评估是否患有过敏性肺炎。此外,在其他DPLD中,稳定的FEV(1)或FVC值可能是诊断过敏性肺炎的线索。然而,需要对更多患者进行进一步研究。